229 related articles for article (PubMed ID: 18322192)
21. Blood leukocytes recapitulate diabetogenic peptide-MHC-II complexes displayed in the pancreatic islets.
Vomund AN; Lichti CF; Peterson OJ; Arbelaez AM; Wan X; Unanue ER
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33822842
[TBL] [Abstract][Full Text] [Related]
22. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
[TBL] [Abstract][Full Text] [Related]
23. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
24. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
25. The central role of antigen presentation in islets of Langerhans in autoimmune diabetes.
Calderon B; Carrero JA; Unanue ER
Curr Opin Immunol; 2014 Feb; 26():32-40. PubMed ID: 24556398
[TBL] [Abstract][Full Text] [Related]
26. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
27. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
28. Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.
Dai YD; Marrero IG; Gros P; Zaghouani H; Wicker LS; Sercarz EE
Diabetes; 2009 Jan; 58(1):156-64. PubMed ID: 18984740
[TBL] [Abstract][Full Text] [Related]
29. The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection.
Suri A; Unanue ER
Adv Immunol; 2005; 88():235-65. PubMed ID: 16227092
[TBL] [Abstract][Full Text] [Related]
30. HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of Islet β-Cells From Donors With Type 1 Diabetes.
Russell MA; Redick SD; Blodgett DM; Richardson SJ; Leete P; Krogvold L; Dahl-Jørgensen K; Bottino R; Brissova M; Spaeth JM; Babon JAB; Haliyur R; Powers AC; Yang C; Kent SC; Derr AG; Kucukural A; Garber MG; Morgan NG; Harlan DM
Diabetes; 2019 May; 68(5):988-1001. PubMed ID: 30833470
[TBL] [Abstract][Full Text] [Related]
31. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice.
Harrison LC; Honeyman MC; Trembleau S; Gregori S; Gallazzi F; Augstein P; Brusic V; Hammer J; Adorini L
J Exp Med; 1997 Mar; 185(6):1013-21. PubMed ID: 9091575
[TBL] [Abstract][Full Text] [Related]
32. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
Guéry JC; Sette A; Appella E; Adorini L
J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
[TBL] [Abstract][Full Text] [Related]
33. Unraveling features of the natural MHC class II peptidome of skin-migrated dendritic cells.
Muixí L; Contreras V; Collado JA; Alexandre Y; Ballingall K; Bonneau M; Jaraquemada D; Schwartz-Cornil I
Int Immunol; 2012 Jan; 24(1):59-69. PubMed ID: 22194283
[TBL] [Abstract][Full Text] [Related]
34. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
Kupfer TM; Crawford ML; Pham K; Gill RG
J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
[TBL] [Abstract][Full Text] [Related]
35. Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice.
Sheng H; Hassanali S; Nugent C; Wen L; Hamilton-Williams E; Dias P; Dai YD
J Immunol; 2011 Aug; 187(4):1591-600. PubMed ID: 21734072
[TBL] [Abstract][Full Text] [Related]
36. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
[TBL] [Abstract][Full Text] [Related]
37. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
[TBL] [Abstract][Full Text] [Related]
38. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
[TBL] [Abstract][Full Text] [Related]
39. Peptide dose, MHC affinity, and target self-antigen expression are critical for effective immunotherapy of nonobese diabetic mouse prediabetes.
Winer S; Gunaratnam L; Astsatourov I; Cheung RK; Kubiak V; Karges W; Hammond-McKibben D; Gaedigk R; Graziano D; Trucco M; Becker DJ; Dosch HM
J Immunol; 2000 Oct; 165(7):4086-94. PubMed ID: 11034420
[TBL] [Abstract][Full Text] [Related]
40. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
